No Moonshots With Paper Planes: Alzheimer's Trials Need Neur

Most Alzheimer's drug trials are using paper measurement tools developed in the 1980's and 1990's. Neurotechnology can do better for patients, while saving us billions.

Related Keywords

Brian Perry , Chris Benko , Bill Gates , Marc Jones , Startup Health , Alzheimer Drug Discovery Fund , Clinical Trials Transformation Initiative , Community Affairs , Digital Medicine Society Di , Development At Inmune Bio , Clinical Dementia Rating , Problem Solving , Personal Care , Digital Medicine Society , Central Nervous Disorder , Cumulus Neuroscience , Mild Cognitive Impairment , Beacon Biosignals , Breakthrough Device , Drug Discovery Fund , Diagnostics Accelerator , Fda , Donanemab , Neurotechnology , Alzheimer S , Digital Biomarkers , Clinical Trials ,